Cialis (tadalafil)
Read about Cialis tadalafil tablets, daily and as-needed presentations, listed strengths and how the original brand compares with other tadalafil products.
- Active ingredient
- Tadalafil
- Form
- Tablets
- EU authorization holder
- Eli Lilly Nederland B.V.
Cialis is the reference tadalafil brand documented here through its EU authorization. Eli Lilly Nederland B.V. is the authorization holder in that record, with a separate batch-release manufacturer named in the product information. Those roles should not be collapsed into one worldwide factory identity.
The strength belongs to a regimen
The EU information distinguishes 2.5/5 mg daily ED treatment from 10/20 mg as-needed presentations. Some 5 mg presentations also cover benign prostatic hyperplasia symptoms. The shared ingredient does not mean every strength has every indication, or that daily treatment can be recreated by adding occasional tablets.
For an ordinary tadalafil tablet, food does not change absorption rate or extent. The longer response window may reduce the need to plan one encounter closely, while also extending medicine exposure. It describes support for a response to stimulation, not a continuous erection.
Ask what a study calls recovery
Research after nerve-sparing prostate surgery found better drug-assisted function with daily tadalafil, without maintained group differences after treatment stopped. That is a specific surgical result, not a promise of permanent recovery for all ED. The tadalafil article explains the study and its limits.
Compare exact products
“Generic Cialis” is a search phrase. A generic needs its own company, formulation and local record. “Cialis Black,” Soft or Professional should not be assumed to identify a Lilly presentation because a seller uses the Cialis name. For daily versus occasional tradeoffs, read the regimen guide; for interactions, use the supplied leaflet and safety overview.
Product record
- Company
- Eli Lilly Nederland B.V. (EU marketing authorization holder)
- Manufacturing
- Lilly S.A., Alcobendas, Spain — manufacturer responsible for batch release in the EU product information.
- Strengths
- 2.5, 5, 10, 20 mg
- Jurisdiction checked
- European Union
- Record reference
- EMEA/H/C/000436
- Treatment area
- Erectile dysfunction (ED)
- Record reviewed
- 4 October 2026; source retrieval dates are retained with the evidence
These records identify a named product and market. They do not confirm stock, authenticate a particular pack, or establish authorization in another country.
About tadalafil
Tadalafil can offer a response window up to 36 hours with stimulation, not a continuous erection. Daily and as-needed regimens differ; food does not change absorption in the reference label. Longer exposure also matters for interactions.
Using a PDE5 inhibitor safely
Never take a PDE5 inhibitor with nitrates, recreational nitrites (“poppers”) or riociguat, and do not combine two ED medicines. Seek urgent medical help for chest pain, an erection lasting more than four hours, or sudden loss of vision or hearing.
Common side effects include headache, flushing, indigestion and a blocked nose.
Sources
2 sources
Checked .
- Cialis assessment and authorization record — European Medicines Agency
- Cialis product information — European Medicines Agency